The Trump administration plans to impose a new testing requirement for new vaccines — a demand that could delay the availability of the next round of COVID-19 vaccines and complicate the ...

A similar paradigm has unfolded for Covid-19 vaccines since they were first authorized in the height of the pandemic at the end of 2020. HHS’s new initiative also aims to develop universal ...

In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine project championed by two scientists who were recently tapped to serve in ...

Prof Trauer said the best protection for people, particularly those who are immunocompromised or vulnerable to Covid, is through vaccination. 'The most recent vaccines are likely to be the most ...

The FDA chief has called into question whether the agency will approve and authorize the COVID-19 vaccine for winter. In August 2024, the U.S. Food and Drug Administration approved the updated ...

Pieter Cullis a co-founder and have shares in Acuitas Therapeutics, the company that provided the LNP enabling the Pfizer/BioNTech COVID-19 vaccine. He receives funding from CIHR. University of ...

In response to questions about whether other vaccines previously safety tested would be newly scrutinized, the department focused on its concerns around the coronavirus vaccine but did not address ...

A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die. A spokesperson for the Cleveland ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune response than having it in the opposite arm, according to a study in mice ...